Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion
- 1 April 1992
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 66 (1) , 23-31
- https://doi.org/10.1016/0049-3848(92)90152-z
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.Circulation, 1990
- Modulation of Leukocyte-Mediated Myocardial Reperfusion InjuryAnnual Review of Physiology, 1990
- Platelet-activating factor and cytokine interactions in shockResuscitation, 1989
- Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog.Circulation Research, 1989
- Effect of Platelet-Activating Factor on Platelets and Vascular EndotheliumSeminars in Thrombosis and Hemostasis, 1989
- Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shockThrombosis Research, 1989
- Is there a case for PAF antagonists in the treatment of ischemie states?Trends in Pharmacological Sciences, 1989
- Salutary consequences of blockade of platelet activating factor in hemorrhagic shockEuropean Journal of Pharmacology, 1988
- Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damageBlood, 1988
- Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shockEuropean Journal of Pharmacology, 1987